Trial Profile
Safety and efficacy of a single dose of dapagliflozin in patients with Hepatocyte Nuclear Factor 1 Alpha (HNF1A)-MODY, Glucokinase (GCK)-MODY, and Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 May 2018
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 02 May 2018 New trial record